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Abstract
Malaria has reemerged in many regions where once it was nearly eliminated. Yet the source of these parasites, the process
of repopulation, their population structure, and dynamics are ill defined. Peru was one of malaria eradication’s successes,
where Plasmodium falciparum was nearly eliminated for two decades. It reemerged in the 1990s. In the new era of malaria
elimination, Peruvian P. falciparum is a model of malaria reinvasion. We investigated its population structure and drug
resistance profiles. We hypothesized that only populations adapted to local ecological niches could expand and repopulate
and originated as vestigial populations or recent introductions. We investigated the genetic structure (using microsatellites)
and drug resistant genotypes of 220 parasites collected from patients immediately after peak epidemic expansion (1999–
2000) from seven sites across the country. The majority of parasites could be grouped into five clonal lineages by networks
and AMOVA. The distribution of clonal lineages and their drug sensitivity profiles suggested geographic structure. In 2001,
artesunate combination therapy was introduced in Peru. We tested 62 parasites collected in 2006–2007 for changes in
genetic structure. Clonal lineages had recombined under selection for the fittest parasites. Our findings illustrate that local
adaptations in the post-eradication era have contributed to clonal lineage expansion. Within the shifting confluence of drug
policy and malaria incidence, populations continue to evolve through genetic outcrossing influenced by antimalarial
selection pressure. Understanding the population substructure of P. falciparum has implications for vaccine, drug, and
epidemiologic studies, including monitoring malaria during and after the elimination phase.
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Introduction
Understanding the population dynamics of malaria parasites
can provide useful insights for malaria elimination programs [1].
The international malaria eradication campaign initiated during
the early 20
th century resulted in the elimination of malaria in
some regions of the world [2,3]. Despite these efforts, malaria
reemerged largely due to the failure of traditional control
programs. It is not well understood how the malaria eradication
campaign altered the population structure of malaria parasites, but
it likely led to population bottlenecks.
In South America, earlier studies of P. falciparum population
structure provided evidence for clonal parasite populations due in
part to bottlenecks caused by control, as well as low transmission
(,1%; [4]), inbreeding, and epidemic expansions. Populations
have limited genetic diversity, high differentiation, and are out of
mutation drift equilibrium (MDE) [4,5,6,7,8,9,10,11,12,13,
14,15]. When populations are in MDE, the number of mutations
entering the population is balanced by the number of mutations
being removed by random change, called genetic drift. The
disruption of MDE indicates the effective population has not been
stable over time. Population differentiation occurred through
fragmentation, genetic drift in small effective population, the
creation of new populations from migrants (founder effect), and
subsequent admixture between sites [4]. Tibayrenc and Ayala
have postulated that P. falciparum propagation may be essentially
clonal in such situations [16,17]. They suggested such lineages be
referred to as clonets, which are genetically identical for a set of
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common ancestors occurring weeks to hundreds of years ago
[16,17].
In this study we investigated the consequences of malaria
eradication and drug pressure on the genetic structure of P.
falciparum populations in Peru. Control efforts achieved near
elimination of malaria from 1966 to 1989 [18]. This ended when
Peru suffered multiple epidemics of malaria during the 1990s [19],
reaching peak incidence in 1998 on the Pacific Coast and in the
Amazon [1,20]. Subsequent control reduced malaria throughout
Peru, particularly on the Pacific Coast. Yet it continues to be
transmitted in the Amazon, with the majority of cases in the
department of Loreto, especially in Iquitos, the largest city in the
region [21]. Due to the resurgence of malaria, clinical trials were
conducted in 1998–2000 and showed that strains from the coast
and the western Amazon were chloroquine (CQ) resistant, but
sulfadoxine pyrimethamine (SP) sensitive, while strains from the
remainder of the Peruvian Amazon were CQ and SP resistant
[1,22]. One study suggested there were two parasite lineages in
Loreto based on pfcrt alleles (SVMNT and CVMNT) [23].
Another suggested there were three lineages based on clinical
resistance (a Brazilian, a Loreto, and a Western Amazon/Pacific
type) [21].
As a consequence of these studies, in 2001 Peru adopted
artesunate plus mefloquine combination therapy (ACT) for the
Amazon region and artesunate plus SP for the coastal region as the
primary P. falciparum treatments [1]. Thereafter, the frequency of
SP resistant alleles of dhfr and dhps significantly decreased in the
Amazon, possibly due to the higher fitness of sensitive alleles. An
earlier shift from CQ to SP in 1995 did not lead to a reduction in
CQ resistant alleles [24,25] because the essential K76T mutation
in pfcrt was fixed [26,27].
These historical events, combined with the availability of
parasite specimens from studies conducted immediately after the
peak of malaria resurgence (1999–2000) and several years after the
introduction of ACT (2006–2007), allowed us to test three
hypotheses: 1) that the resurgence of P. falciparum after the
eradication era may have been due to a) clonal expansion of
residual parasites or b) expansion of recently introduced parasites
from elsewhere in South America; 2) that regional differences in
drug resistance profiles may suggest underlying population
structure with the Andes Mountains acting as a barrier to gene
flow; 3) that changes in drug policy a) only altered the frequency of
resistant alleles and did not influence the frequency of alleles
elsewhere in the genome during the period of increased malaria
transmission or b) influenced both due to limited opportunities for
sexual recombination.
Materials and Methods
Ethics Statement
The parasite samples used in this study were obtained from
sample collection protocols that were approved by the Ethical
ReviewCommittees of the Instituto Nacional de Salud(fornorthern
Pacific Coast), US Naval Medical Research Center Institutional
Review Board and the National Institutes of Health of Peru (for
Peruvian Amazon); and Institutional Review Boards of the U.S.
Army, the U.S. Navy, and the Universidad Cayetano Heredia (for
central and northeastern Amazon) [20,22,24,25,26,28] as well as
the U.S. Centers for Disease Control and Prevention. Written
informed consent was provided by study participants and/or their
legalguardians.Samplesobtained fromIquitoswasapprovedbythe
U.S. Naval Medical Research Center Institutional Review Board
(approval no. NMRCD.2000.0006).
Study Sites and P. falciparum Clinical Isolates
We examined 220 Peruvian P. falciparum clinical isolates
collected during 1999–2000 from the northern Pacific Coast
(Bellavista, n=2; La Arena, n=11 and Zarumilla, n=67), the
western Peruvian Amazon (Pampa Hermosa, n=10; Ullpayacu,
n=25) collected during drug efficacy trials [20,22,25], and from
the central Peruvian Amazon (Padre Cocha, n=65) and the
eastern Peruvian Amazon (Caballococha, n=40) collected during
drug efficacy trials and surveillance studies [24,26,28].
We also examined 62 Peruvian P. falciparum clinical isolates
collected during 2006–2007 in Iquitos during an ongoing febrile
surveillance study. We used the Padre Cocha isolates as a historical
comparative time point for Iquitos.
DNA Isolation, PCR Amplification and Genotyping of dhfr,
dhps, pfcrt, and pfmdr1
DNA was isolated from filter paper blood spots [22,25,26] or
whole blood [26] using the QIAamp DNA blood mini kit (QIAGEN,
Valencia, CA). Samples from Padre Cocha, Caballococha, and
Iquitos were previously sequenced for point mutations in dhfr, dhps,
pfcrt,a n dpfmdr1[26].Limitedsamplesfromthesesites,aswellasfrom
the Iquitos, were resequenced for dhps to test for a novel synonymous
dhps mutation at codon 540 (AAG). Sequencing of dhfr and dhps in
Pampa Hermosa and Ullpayacu samples were previously reported
[22] and were resequenced for confirmation. Samples from
Bellavista, La Arena, Pampa Hermosa, Ullpayacu, and Zarumilla
were sequenced for pfcrt, pfmdr1,a n ddhps using protocols described
previously [9,29]. A nested PCR protocol was utilized for dhfr,w i t h
outer forward primer 59-TCCTTTTTATGATGGAACAAG-39
and outer reverse primer 59-AGTATATACATCGCTAACAGA-
39. The secondary reaction, utilized 59-TTTATGATGGAACA-
AGTCTGC (forward) and 59-ACTCATTTTCATTTATTTCT-
GG-39 (reverse) primers. The cycling conditions were 94uC/5 min;
35 cycles of 95/30 sec, 50/30 sec, 68/1 min; 68uC/5 min (primary
reaction) and 94uC/5 min; 30 cycles of 95uC/30 sec, 52uC/30 sec,
68uC/1 min; 68uC/5 min (secondary reaction).
Microsatellite Typing
Whole genome amplified DNA (Qiagen’s REPLI-g Whole
Genome Amplification Kit, Valencia, CA) was used for microsat-
ellite characterization. Samples were assayed for 12 microsatellite
loci spanning 499.5 kb around pfcrt on chromosome 7; 15
microsatellite loci spanning 544.7 kb around pfmdr1 on chromo-
some 5; 13 microsatellite loci spanning 700 kb around dhfr on
chromosome 4; and 16 microsatellite loci spanning 406.3 kb
around dhps on chromosome 8 [30,31,32]. Primer sequences and
their PCR parameters were described earlier [9,11]. We
previously reported microsatellite data close to dhfr, dhps, pfcrt,
and pfmdr1 for Caballococha and Padre Cocha [26]. In an earlier
paper, we created haplotype identifiers for each of these genes
based on microsatellite loci that were nearby [26] These
haplotypes are denoted by suffixes after gene alleles and their
lettering scheme is not related to the identifiers used for clonets. In
addition, we examined 12 putatively neutral microsatellite loci.
Five were selected from neutral markers previously described
(TA1, chromosome 6; poly a, ch. 4; PfPK2, Ch. 12; TA109, ch. 6;
and 2490, ch. 10) [4,33]. The remaining seven markers were
C2M33, C2M34, C2M29, C2M27 on ch. 2; and C3M40,
C3M69, and C3M39 on ch. 3 [11].
Statistical Analysis
We used seven microsatellites on different chromosomes (TA1,
poly a, PfPK2, TA109, 2490, C2M34, and C3M69) to examine
Peruvian P. falciparum after Eradication
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locus-by-locus hierarchical analysis of molecular variance
(AMOVA) was used to partition variation among and between
all populations, as well as between coastal and all Amazonian sites
using Arlequin version 3.1 [34]. Significance of the fixation indices
was determined using a non-parametric approach. FST was
calculated among all populations, with the exception of Bellavista
because it was represented by only two samples, and between all
pairs of populations. The significance of F statistics and genetic
variance components were tested using 1,000 permutations [34].
We also used FST to compare clonal lineages.
Isolation by distance was tested by regressing pairwise FST on
pairwise geographic distances among populations [35] and
significance determined with Mantel’s tests (1,000 permutations)
using Arlequin [34]. We tested whether grouping our samples by
apparent ancestral populations explained more genetic variation
than grouping them by collection sites using AMOVA. We initially
examined the seven neutral markers and then expanded to all
microsatellite markers including those considered neutral and
flanking drug resistance genes, with the exception of dhfr: 0.52 kb
and dhps: 9.0 kb.
Significant associations between microsatellite loci within
clonets were determined using an exact test of linkage disequilib-
rium (LD) [36] and 10,000 Monte Carlo steps in Arlequin version
3.1 [34] and a Bonferronni-Holms correction [37].
We tested for bottlenecks using Bottleneck (www.ensam.inra.fr),
which assumes that utilized markers are neutral and not in LD,
and that populations lack substructure, migration, and hybrids.
When a population is at MDE, each microsatellite should have an
equal probability of having an observed He deficit or excess in
comparison to the expected He based on the number of alleles.
After a bottleneck, there will be a reduction in the number of
alleles and He at polymorphic loci. However, allelic diversity
decreases at a faster rate than He during a bottleneck. Therefore, a
bottleneck is indicated if a significant number of loci have a He
excess compared to that expected if the population was in
mutation-drift equilibrium. Conversely, if there is He deficit, the
population will also no longer be in MDE and a rapid population
expansion is indicated. To test whether our populations were in
MDE, we used a sign test, which assumes a null hypothesis of
MDE, but has low statistical power. To test for He deficits and
excesses, we used a Wilcoxon sign-rank test [38]. We used a two-
phased model of mutation for all tests [38] and included the seven
neutral markers, as well as four markers from each chromosome
carrying one of the genes (Ch. 4, 347.1 kb; Ch. 5, 2305 kb; Ch. 7,
2257 kb; and Ch. 8, 2196.6) selected to be as far from the genes
as possible.
Network Analysis
We created two median-joining network diagrams using
Network v. 4.516 (fluxus-engineering.com) [39]. First, we used
the seven microsatellites previously described to examine samples
collected between 1999–2000 for clonal structure, but did not
include the additional four markers in order to maximize the
sample size; there were samples, particularly those collected in the
Western Amazon, which we would have had to exclude if we had
included all eleven markers. Second, we expanded to the eleven
microsatellites for another network diagram to illustrate the
genetic relationships between isolates collected in Iquitos and
isolates from 1999–2000, though this reduced the number of
usable samples. Additional markers were included in the second
network diagram to increase the resolution of our network
diagram and to demonstrate the robustness of our findings.
Results
Analysis of Population Structure in 1999–2000 Reveals
Clonal P. falciparum Lineages
We analyzed P. falciparum isolates from sites across Peru
collected during 1999–2000 to understand underlying population
structure. For FST analysis, seven neutral microsatellite markers
from different chromosomes were used. Statistically significant
pairwise FST ranged from 0.22 (Padre Cocha and Pampa
Hermosa; Padre Cocha to Caballococha) to 0.9 (Zarumilla and
Ullpayacu), which suggests the parasites from various sites are
differentiated (Table 1). Padre Cocha is most similar to
Caballococha and Pampa Hermosa, and more differentiated from
La Arena, Ullpayacu, and Zarumilla. The significant differentia-
Table 1. Pairwise FST by Collection Site or Clonet.
Study Sites n* Zarumilla La Arena Padre Cocha Caballococha Pampa Hermosa
Zarumilla 66 - - - - -
La Arena 11 0.58 - - - -
Padre Cocha 58 0.61 0.40 - - -
Caballococha 38 0.62 0.39 0.22 - -
Pampa Hermosa 7 0.48 0.28 0.22 0.31 -
Ullpayacu 24 0.90 0.85 0.52 0.55 0.77
Clonet n A B C D E
A 3 0 - - ---
B 22 0.80 - - - -
C 33 0.80 0.83 - - -
D 42 0.83 0.85 0.70 - -
E 81 0.86 0.84 0.89 0.78 -
Pairwise FST values calculated when comparing different collection sites or clonets using the 7 neutral markers described in the text. All values are significantly different
from zero (p#0.05).
*n denote sample size.
doi:10.1371/journal.pone.0023486.t001
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the limited sampling of La Arena (n=11), as they had the same
circulating neutral alleles. Ullpayacu is highly differentiated from
all the other sites. Pampa Hermosa is most similar to La Arena and
Padre Cocha. No isolation by distance was found in Peru based on
the Mantel test (R
2=0.01, p=0.447).
The lack of spatial population structure, and prior evidence
suggesting clonality in South America, led us to examine
population structure based on grouping parasites into clonal
lineages. We identified five clonal lineages in multilocus linkage
disequilibrium (LD) using the same seven neutral satellite markers.
Each clonal lineage carried one allele at each locus in 80–100% of
isolates and we designated them clonets A, B, C, D, and E
(Table 2). Statistically significant FST values between the clonets
exceeded 0.70 in all cases, suggesting high differentiation between
them (Table 1). We also illustrate that each clonet has few
polymorphic markers and levels of pairwise LD for the remaining
polymorphic that are higher than the expectation of random
chance (p=0.05; Table 2). Applying AMOVA to these markers,
only 27% of variation was explained by comparing sampling sites
while 68% of variation was explained by clonets (Fig. 1).
Furthermore, when the AMOVA was expanded to all 66 markers,
partitioning the data by site only explained 7% of the variation
(data not shown), while clonets explained 76% of variation. The
Figure 1. AMOVA Results. Locus by locus AMOVAs were used to create this table. N denotes sample size. Haplotype group refers to a combination
haplotype of the haplotypes seen around each of the four genes. ** Two apparently monomorphic markers were removed from analysis (dhfr:
0.52 kb and dhps: 9.0 kb) due to poor amplification in clonet D.
doi:10.1371/journal.pone.0023486.g001
Table 2. Most common alleles in clonets.
Clonet
TA1,
1,
Ch. 5
2
poly a,
Ch. 4
PfPK2,
Ch. 7
TA109,
Ch. 6
2490,
Ch. 10
C2M34,
Ch. 2
C3M69,
Ch. 3
Monomorphic
markers, 66
markers
4
Pairwise LD in
polymorphic
markers
A 169; 84%
3 172; 100% 166; 93% 164; 100% 84; 93% 240; 100% 132; 55% 70%; n=29 11%
B 172; 90% 183; 100% 172; 100% 164; 85% 84; 100% 226; 100% 149; 100% 58%; n=23 12%
C 178; 56% 164; 97% 163; 97% 160; 94% 80; 85% 246; 85% 136; 85% 40%; n=33 30%
D 178; 56% 161; 80% 175; 82% 160; 100% 80; 98% 233; 100% 122; 100% 44%; n=39* 31%
E 172; 99% 148; 99% 175; 84% 160; 99% 74; 83% 226; 100% 138; 83% 83%; n=84 21%
Values represent most common fragment sizes in nucleotides, followed by the percentage of isolates carrying them.
*Two apparently monomorphic markers were removed for analysis of clonet D due to poor amplification (dhfr:0 . 5 2k ba n ddhps: 9.0 kb).
1The microsatellite loci name.
2its chromosome,
3the first value indicates the common allele size and the second is the percentage of isolates carrying it.
4The column represents the number of monomorphic markers out of the total 66 markers examined in this study as a percentage, along with the number of samples
used to calculate this value.
doi:10.1371/journal.pone.0023486.t002
Peruvian P. falciparum after Eradication
PLoS ONE | www.plosone.org 4 September 2011 | Volume 6 | Issue 9 | e23486clonality is also illustrated by the few polymorphic markers in each
clonet and high levels of pairwise LD for the remaining
polymorphic markers (Table 2). All subsequent analyses defined
populations based on clonets because it maximized population
differentiation.
Genetic Relatedness between Clonets and Their
Geographic Distribution
The distribution of different clonets and their relative
proportions at each site is indicated in figure 2. The Pacific coast
sites (Bellavista, La Arena, and Zarumilla) only had the E clonet.
Ullpayacu, a western Amazon site, had only the D clonet, with the
exception of one sample from the C clonet. Despite limited isolates
from Pampa Hermosa, both the C and E clonets were found. In
Padre Cocha, clonets A, B, C, and D were found, while in the
Caballococha the A, B, and D clonets were found. The geographic
distribution of these clonets suggested that the highest amount of
admixture could be found in Padre Cocha, the site closest to
Iquitos. A median joining network analysis was performed to
understand the genetic relatedness between the clonets (Fig. 3).
This analysis indicated clonet B is only linked to clonet A, clonet C
is only linked to clonet D, and clonet E was only linked to clonet
D, which suggested the potential shared ancestry of these pairings.
However, Clonet D was found at many sites and linked to clonets
A, C, and D, suggesting it could have sexual recombined with
some of them.
Evidence for Clonet Bottlenecks or Population
Expansions
Testing for bottlenecks requires polymorphic markers which are
inherently difficult to locate in clonets. Overall, clonets A, B, and E
had more monomorphic markers than clonets C and D. Clonet E
has the least microsatellite variation. The sign test did not reject
MDE for any of the clonets, though it was almost rejected for
Figure 2. Sample Collection Sites and Distribution of Clonets. A map of Peru that shows the collection sites, as well as the Andes Mountains
(dark gray), roads of interest (black lines over Andes), and rivers of interest in the Amazon (light gray). Iquitos is omitted from the map. It is locatedi n
the black dot representing Padre Cocha. Roads and rivers are drawn in yellow and blue respectively. They are not meant to represent all of the roads
in Peru and are truncated in Ecuador. They were included in order to suggest how parasites could have migrated within Peru and been introduced
through Ecuador. The proportion of clonets in study sites is indicated in the map legend and pie charts.
doi:10.1371/journal.pone.0023486.g002
Peruvian P. falciparum after Eradication
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clonet E had a significant He excess (p=0.03), suggesting a recent
bottleneck. Only clonet B had a significant He deficit (p=0.03),
indicative of a rapid expansion.
Drug Resistance Associated Alleles Correlate with Clonets
We hypothesized that the distribution of clonets at collection
sites might be associated with the drug resistance profiles seen in
different regions (Fig. 4). To test for drug resistance genotypes, we
amplified and sequenced four genes (pfcrt, pfmdr1, dhfr, and dhps)
previously implicated in resistance. Triple mutant dhfr alleles were
found almost exclusively in clonets A and B, with the exception of
two isolates belonging to clonet C (potential recombinants). Triple
mutant dhps alleles were exclusively found in clonet A, while clonet
B had only the double mutant dhps allele, except the same two
potential recombinants as above. Clonets A and B carried CQ
resistant pfcrt allele SVMNT-A. Clonet C carried CVMNT-A, an
allele that may be ancestral to SVMNT-A. Clonet C also carried a
single mutant dhfr allele (108N-B) in most cases, along with the
wild type dhps-A allele, which may have been ancestral to the
alleles found in clonet A and B. Clonets D and E carried SP
sensitive alleles. Clonets D and E carried a CVMNT-B allele not
shared with clonet A, B, or C. Clonet D carried a 108-C dhfr allele
and a unique dhps wild type allele with a synonymous mutation at
codon 540. Clonet E carried a dhfr wild type allele or a mutant
108-D. It also carried a dhps wild type-C allele. Two major pfmdr1
lineages (a and b) were found. These were based on the proximal
21.40 and 0.45 kb microsatellite markers [26]. The a lineage had
a 197 bp in length allele and a 191 bp in length allele at the two
respective loci, while the b lineage had a 203 bp and a 178 bp
alleles. The a lineage was predominately seen in the A, B, and C
clonets, along with a few samples from the D clonets. The b pfmdr1
lineage was only seen in the C, D, E clonets. The multilocus LD
seen between the 66 microsatellite markers extended to pfcrt,
pfmdr1, dhfr, and dhps alleles. However, the multilocus lineages had
partially broken down in a few isolates carrying clonet C and D,
particularly those isolated in Padre Cocha. This suggests there
may have been some reassortment and recombination.
Clonet Breakdown and Selection Due to Increased
Transmission, Diversity, and Drug Pressure
To test whether changes in the drug policy has influenced
population dynamics, we compared the 1999 clonet profile and
resistant lineages with the 2006/7 data from Iquitos (Table 3 and
Fig. 5). With no interbreeding, the clonet structure in Iquitos should
have been maintained (persistence of clonets A, B, C, and D). If
there had been panmixia, we would have expected hybridization
between at least some of these clonets (Fig. 6 and Table 3). Isolates
from 2006–07 often clustered independently from clonets A, B, C,
D andE ina medianjoining network (Fig.5),though some clustered
with clonet B, and a very few with clonets A,C, and D. A large
number of isolates were hybrids of clonet B and C or C and D
(Table 3). Additional recombination between clonets A, B, and C,
or B, C, and D is suggested by the few remaining samples. As clonet
A was in high frequency in 1999 in Padre Cocha, the scarcity of
clonet A hybrids in 2006–07 was surprising. On the other hand,
hybrids of clonet C and B were at higher frequency than expected
through random mating. Taken together, this suggests that there
Figure 3. Network Analysis of Clonets Integrated with Study Sites. Network diagram showing the genetic relationships among the A, B, C, D,
and E clonets and collection sites from 1999–2000 using the seven neutral microsatellite markers described in the text. Small red circles represent
hypothetical nodes that link haplotypes seen among our samples.
doi:10.1371/journal.pone.0023486.g003
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(Table 3 and Fig. 5). While pairwise LD appeared similar to that
seen in 1999–2000, the number of monomorphic markers
decreased, as only 8 of the 66 markers were monomorphic
(n=32) though 28% of comparisons were in significant linkage.
Discussion
This study indicates that Peruvian P. falciparum populations
expanded from bottlenecked populations or migrants in the post-
eradication era. During the peak malaria incidence (1998–2000),
Peruvian parasite populations consisted of at least five clonal
lineages with varying drug resistant genetic backgrounds. Since the
1990s the increase in the transmission intensity has favored sexual
recombination, especially in the Central Amazon region. Simul-
taneously, changes in drug policy seem to have been a critical
selective force. We argue that the combination of increased
opportunities for outcrossing and changes in drug policy strongly
influenced population structure and parasite evolution between
the study time points.
Previous studies have suggested that low transmission could
maintain linkage disequilibrium in P. falciparum [4,6,9,10,11,
12,40,41]. However, the mechanisms underlying population
differentiation in low transmission areas have not been explained,
beyond invoking genetic drift [4,7,42] or, rarely admixture [4].
Our study clearly demonstrates how these factors have influenced
parasite populations. We demonstrate how clonet expansion and
migration can alter parasite population structure in a region after
the era of eradication. We show that multiple clonets can be
maintained in sympatry if there is not sufficient transmission for
outcrossing.
Historical malaria eradication may have reduced parasite
populations to a patchy network of refuges in areas of low P.
falciparum transmission like South America [3,43]. These refuges
could be interpreted as the kind of islands that Sewall Wright
addressed with his island model of population structure [41]. In
the island model, the population is subdivided into subgroups with
each breeding within itself, except for migrants [44]. These
subgroups can be due to geography, ecology, or time [45]. In the
case of South America, malaria eradication would have led to
separated, allopatric parasite refuges. These, in turn, would have
eventually led to clonal lineages developing through genetic drift
and inbreeding. After malaria eradication efforts waned, such
populations would have expanded locally and begun to migrate to
other islands of inbred parasites. The opportunities for outcrossing
between these coexisting, sympatric, clonets would have been
limited because of the low frequency of multiple infections in a low
transmission environment.
The demonstration that Peru had at least five clonal lineages of
P. falciparum in the post eradication era is consistent with other
recent studies around Iquitos [46,47]. In one, whole genome
sequences of 14 P. falciparum isolates led to the conclusion that the
isolates were largely identical, with at most four parental
haplotypes [47]. Another argued that five independent clusters
of related subpopulations exist based on microsatellite data
collected between 2003–2007 [46]. Our study was able to draw
Figure 4. Drug Resistance Multilocus Linkage Disequilibrium. The multiallelic disequilibrium seen across multiple genes and microsatellite
markers.
aHaplotype groups are summaries of the haplotypes found for the following four columns.
b‘‘?’’ means that there was incomplete or
unknown data for this cell. The final column suggests the subvariants seen within each clonet amongst the seven neutral markers. Notice that clonet
C was found with both pfmdr1 lineages; while we would argue the a is ancestral, there is no direct proof of this. In cases were reassortment or
recombination appears to have occurred, we have suggested the secondary clonet with a subscript (e.g. CA was most likely a cross between clonet A
and C.) SYN is an abbreviation for synonymous. Each clonet is identified by a unique color and the color coding is also used in the figures.
doi:10.1371/journal.pone.0023486.g004
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the country. Furthermore, many samples were collected around
1999, after the peak of the malaria resurgence, which suggests that
only a few lineages were involved.
Genetic drift caused by self-mating, mitotic replication, or other
processes is an important source of genetic diversity in areas of
clonal propagation like South America. Over the short term,
however, clonets might have been maintained if there was only
one clonet present in each locality, as on the Pacific coast of Peru,
or had there been insufficient transmission for outcrossing to occur
among clonets. We argue that the increase in malaria transmission
in the late 1990s led to admixture and cryptic parasite population
substructure (Fig. 4). Furthermore, we argue that the rapid
increase in malaria transmission during the late 1990s led to
sufficient multiple infections for clonet outcrossing to occur and
that this was a greater influence on genetic diversity than the
genetic drift that likely generated the clonets. Another recent study
has confirmed the frequent occurrence of recombination in this
region as 33.6% of infections examined in a cohort study involving
villages near Iquitos between 2003–2007 were mixed, with a
decrease in LD over time, and recombination in later years [46].
Clonal substructure was found at all of the collection sites in the
Amazon interior (clonets A, B, C, D, and E) and a single clonet
expansion was found on the northern Pacific coast (clonet E). The
Andes appeared to act as a semi-permeable barrier to gene flow,
but, within the Amazon interior no barrier was found. Though the
coastal (clonet E) and western Amazon sites (C and E vs. D and C)
do not share many clonets, Caballococha (A, B, C) and Padre
Cocha (A, B, C, D) shared three. The presence of a few clonet E
isolates in Pampa Hermosa suggests a recent introduction, perhaps
in the early 1990s, to the Western Amazon by way of Andean
roads that terminate near Pampa Hermosa [48]. The comparative
genetic diversity seen in Padre Cocha is not surprising given its
close proximity to Iquitos, where ,42% of Loreto’s population
lives [21]. Iquitos has a large enough population to support
multiple lineages, is a hub of human movement, and many P.
falciparum cases were reported there, allowing for potential multiple
infections and recombination.
Historical facts about the origins of CQ and SP resistance in
different time points allow us to speculate when different clonets
may have migrated to Peru. The first reports of CQ resistance in
Peru occurred in the eastern Amazon in 1979–1980, while
parasites to the south remained CQ-sensitive [48,49]. Peruvian
reports occurred decades after the first continental reports from
Venezuela (1959; [50]) or Rondo ˆnia, Brazil (1960; [50]). It was
suggested that resistance may have spread from coastal and
interior Ecuador, where it was reported as early as 1976
[21,50,51]. However, nearby Rondo ˆnia, Brazil might have also
been a source of Peruvian CQ-resistant parasites. Molecular data
suggested at least two independent origins for CQ resistance in
South America [32], which we identified as the pfcrt CVMNT-B
allele (coastal and western regions of South America) and the
CVMNT-A/SVMNT-A alleles (Amazon). Our data indicates that
these two CQ resistant lineages have colonized Peru with the
CVMNT-A/SVMNT-A alleles mostly occurring in the eastern
and central Amazon region and the CVMNT-B allele on the
Pacific coast and in several sites in the Amazon [32]. SP resistance
was proposed to have developed in the Amazon as early as the
1970s and spread regionally [7,52], but was not reported in Peru
until the 1990s.
We were able to hypothesize when the five clonets were
introduced into Peru based on their drug resistance profiles.
Table 3. Drug resistance allele haplotypes seen in Iquitos in 2006–2007.
n* Haplotype group dhfr pfcrt dhps pfmdr1
1 AAAa 51/108/164-A SVMNT-A 437/540/581-A a-184/1034/1042
6
i AAAa 51/108/164-A SVMNT-A 437/581-A a-184/1034/1042/1246
1 AAAb 51/108/164-A SVMNT-A 437/581-A b-142/184/1042
3 DAAa 50/51/108-D SVMNT-A 437/540/581-A a-184/1034/1042/1246
1 AAAb 51/108/164-A SVMNT-A WT-A b-142/184/1042
1 ABAb 51/108/164-A CVMNT-B WT-A b-142/184/1042
17
ii BAAa 108-B SVMNT-A WT-A a-184/1034/1042
5 BAAa 108-B SVMNT-A WT-A a-184/1034/1042
1 BAAb 108-B SVMNT-A WT-A b-142/184/1034/1042
2 BAAb 108-B SVMNT-A WT-A b-142/184/1042
1 BAAb 108-B SVMNT-A WT-A b-184/1042
3
iii BAAa 108-B CVMNT-A WT-A a-184/1034/1057
12
iv BBAb 108-B CVMNT-B WT-A b-142/184/1048
1 BBAb 108-B CVMNT-B WT-A b-142/184/1034/1042
1? B A b ? CVMNT-B WT-A b-142/184/1049
2 CBCb 108-C CVMNT-B WT-C b-184/1034/1042
2
v CBBb 108-C CVMNT-B WT-AAG-B b-184/1034/1042
The multiallelic linkage disequilibrium between drug-resistance alleles. It does not include neutral haplotypes because of the extent of chromosomal reassortment.
i5/6 of these samples represented clonet B.
ii16/17 of these samples appear to represent the same combination of clonet B and C.
iii2/3 of these samples represented clonet C.
iv7/12 of these samples represented the same combination of clonet C and D.
vThese samples represented a combination of clonet C and D.
*n denotes sample size. Haplotype group refers to a combination haplotype of the haplotypes seen around each of the four genes.
doi:10.1371/journal.pone.0023486.t003
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with highly resistant dhfr and dhps alleles (noted in the Amazon by
others as well [7]), along with the pfmdr1 a lineage. Therefore, it
appears clonet A and B may have swept through the Amazon
basin from Brazil and expanded during the late 1990s when SP
was introduced for primary treatment of malaria in Peru (Figure 7).
The absence of the A and B clonets in the western Peruvian
Amazon and the coast may be due to their recent introduction to
Peru, limited internal migration, lack of widespread SP use,
control efforts, the Andes Mountains, and/or differences in vector
populations. Our interpretation is consistent with our data
suggesting recent population expansion of clonet B. We stress
that testing for MDE, bottlenecks, and population expansions
requires polymorphic markers, which are difficult to locate in
clonets. Clonet A did not share a similar signature of recent
expansion, which might have been due to an earlier introduction
to the region, a more diverse founding population, or outbreeding
with clonets B and/or C based on shared neutral markers.
Clonet C carried the CVMNT-A allele, lacked highly resistant
SP- resistant genotypes, and was only found in Padre Cocha and
Pampa Hermosa. Indeed, a previous study using samples from
across South America only reported this allele in Padre Cocha
[32]. Furthermore, a CVMNT allele that grouped with SVMNT
was reported among 12 samples collected in Iquitos and two
samples from Tabatinga, Brazil, which neighbors Caballococha
[15], suggesting clonet C may have also been found in the Amazon
basin bordering Peru. Clonet C carried mostly SP sensitive dhfr
and dhps genotypes, which may share ancestry with the alleles
found in clonet A and B. Therefore, it is reasonable to argue that
clonet C may represent a vestige of an ancestral Amazonia lineage
which has been present in Peru for a sufficient period to allow
recombination with other clonets. It may be a remnant of the CQ-
resistant lineage hypothesized to have developed in southern
Rondo ˆnia. This would imply it entered eastern Peru from Brazil
sometime after the development of CQ resistance in Rondo ˆnia in
1960, but prior to the development of SP resistance (Figure 7).
Clonets D and E had divergent neutral backgrounds and were
associated with the CVMNT-B allele, the pfmdr1 b lineage, but not
the highly resistant SP genotypes. Based on these commonalities
between the clonets D and E, we propose that these two clonets may
have spread from the Colombia to Ecuador and then Peru (Figure 7).
Clonet D carried a unique 108-C dhfr haplotype and a unique
synonymous 540 dhps mutation not reported elsewhere in South
America, potentially indicating genetic drift. Clonet D may represent
the CQ-resistant coastal lineage that was argued to have spread from
the coast of Ecuador between 1976 and 1980 [53]. It may have
spread from Padre Cocha and Caballococha into Ullpayacu or from
a bordering Ecuadorian site [48]. Our findings suggest that clonet C
a n dDma yh a v eb e e ni nP e r u v i a nA ma z o nlo n g e rt h a ncl o n e tAo rB ,
though the recent history of clonet E is ambiguous.
Clonet E was likely introduced to coastal Peru from a more
direct coastal migration sometime after 1976 and recently spread
into the Peruvian Western Amazon. Clonet E had the least
microsatellite variation of the clonets and our analysis suggests this
clonet has undergone a bottleneck. However, there was a rapid
increase in malaria cases in the region during the 1990s and our
Figure 5. Network Analysis of Clonets in 1999 and Relatedness to Iquitos Clonets in 2006–2007. A network diagram of Iquitos in
comparison to clonets calculated from neutral marker data from 1999–2000. This network diagram shows the genetic relationships between Iquitos
and the previously reported clonets A, B, C, D, and E using the eleven neutral microsatellite markers described in the text. Small red circles represent
hypothetical nodes that link haplotypes seen among our samples.
doi:10.1371/journal.pone.0023486.g005
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statistically significant population expansion might have been
caused by more than one clonet E-like lineage invading Peru since
1976 or the sheer lack of genetic diversity overwhelming the
statistical test. However, there was a rapid increase in malaria
cases in the region during the 1990s and our study suggests that
only clonet E was present.
Our findings suggest that the two pfmdr1 lineages, a and b, have
different geographical distributions. Based on our data we predict
the a haplotype (found in clonets A, B and a major subset of C, and
a few from D) evolved in the Amazon interior of South America
while the b pfmdr1 haplotype (clonets D, E, and to a lesser extent C)
evolvedonthePacificCoastorthenearbywesternAmazoninterior.
The breakdown in this pattern in clonet C and D is presumably due
Figure 7. Hypothesized Spread of Clonets Across Peru. Clonet A: orange, B: green, C: purple, D: blue, E: brown. Our hypothesis of how these
clonets may have spread through Peru is described in the text. In brief, we suggest that clonets A and B may have been recently introduced from the
greater Amazon Basin, that clonet C may represent an older vestigial population, that clonet D may have been introduced during the 1980s from
theAmazon interior of Ecuador, and that clonet E may represent a coastal lineage that has recently invaded the interior of Peru.
doi:10.1371/journal.pone.0023486.g007
Figure 6. Schematic of Changes in Clonet Profiles between 1999 to 2007. Each circle represents a different clonet. After the removal of SP,
the four clonets seen in Padre Cocha have been reduced in size in favor of a number of hybrids. The most common of these represent hybridizations
of clonet B and C or C and D. Note, however, that the lack or low levels of other simple crosses of the various clonets, which suggests selection by
drug pressure may have influenced surviving offspring.
doi:10.1371/journal.pone.0023486.g006
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Colombia, Brazil, and Guyana, which found that pfmdr1 haplotypes
from Colombia and Guyana were quite distinct [12].
Clonet breakdown in Iquitos (2006–2007) indicates recombina-
tion between four different clonets multiple times over the
preceding 7–8 years due to increased transmission. There were
only a small number of original clonets seen in this region in 1999
(clonets A,B,C, and D) that persisted until 2006–2007 (Table 3).
The remaining isolates appeared to be recombinants of clonets B
and C, C and D, or, in a few isolates, recombinants of clonets B,
C, and D or A, B, and C. We suggest the frequencies of these
recombinants are at least partly influenced by the replacement of
SP with ACT in this region in 2001. In support of this argument,
the SP resistant clonets A and B rapidly declined by 2006–2007
and we showed earlier that the SP resistant genotypes they carried
had significantly declined during this period [26,54]. But beyond
this, there was a distinct absence of clonet hybrid offspring which
carried SP resistant alleles in 2006–2007 (Table 3), even though
parasites carrying these alleles had been prevalent in 1999. If such
sexual recombination was just as likely to have occurred, the
marked decline of offspring with SP resistant profiles suggests they
had lower fitness after SP was removed. These observations
illustrate that the parasite clonal lineages underwent rapid changes
in population structure due to the increase in malaria, which
allowed for outbreeding at the same time that new drug policies
altered selection pressure.
Given the large scale migrations within the Amazon basin,
periodic epidemics [55], and changes in drug policy there may
have been opportunities for outcrossing to occur outside of Peru
along with selection pressure from various drugs. Yet it appears
that SP resistance may be fixed in the remaining Amazon basin [7]
and therefore, multiresistant parasites are likely to persist. This is
true in Venezuela, where pfcrt, pfmdr1, dhfr, and dhps were linked [9]
and other parasites were in linkage for various antigenic genes
[13,56,57]. However, SP sensitive parasites could disperse into the
greater Amazon from Peru due to the development of the
Interoceanic Highway, which will connect Atlantic ports of Brazil
with Pacific ports of Peru. As countries in the region have moved
away from SP use, these SP sensitive parasites may outcompete the
already established resistant parasites. Indeed, such migration may
have already occurred based on the presence of SP sensitive dhfr
and dhps alleles in the Colombian Amazon [58]. In summary, our
study suggests that the molecular characterization of population
structure and drug resistance profiles of P. falciparum will provide
valuable insight into how control programs influence the
underlying dynamics and evolution of parasites. Such studies
may help to predict the genetic profiles (eg: drug resistant profile)
of vestigial parasite populations during and after malaria
elimination programs and predict the genetic profiles of parasites
that may reappear in subsequent outbreaks.
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